Results 1 to 10 of about 280,195 (357)

A review on the Role of FLT3/FL System in Non- Hodgkins Lymphoma

open access: diamond, 2021
Darshana Kottahachchi   +3 more
openalex   +2 more sources

A phase II, open‐label, multicenter study of capivasertib, a potent, oral pan‐AKT inhibitor, in patients with relapsed or refractory B‐cell non‐Hodgkin lymphoma (CAPITAL) [PDF]

open access: bronze, 2023
Daniel J. Hodson   +21 more
openalex   +1 more source

Diagnostic criteria and new therapeutic options for patients diagnosed with non-Hodgkin lymphoma

open access: yesArchivo Médico de Camagüey, 2019
Background: malignant haemopathies increase their incidence and proliferation within the population, among them the lymphoproliferative syndrome occupies an important place, it is a group of disorders of clonal origin, which affects the lymphoid cells ...
Yaimé Moreno-Laguard   +5 more
doaj  

Non-Hodgkin lymphoma as a cause of acute intestinal obstruction/perforation in patients with adenocarcinoma of the sigmoidcolon: a case report [PDF]

open access: hybrid, 2011
Marcelo Pandolfi Basso   +4 more
openalex   +1 more source

Intraoral Swelling: A Rare Case Report with Diagnostic Perplexity

open access: yesJournal of Indian Academy of Oral Medicine and Radiology
Non-Hodgkin lymphomas are malignant tumor that arises from the lymphoreticular system. Anaplastic large cell lymphoma (ALCL) is a type of non-Hodgkin lymphoma distinguished by the proliferation of pleomorphic large lymphoid cells expressing CD30 antigen.
Vikram Singh   +3 more
doaj   +1 more source

The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma

open access: yes, 2016
The REL gene, encoding the NF-κB subunit c-Rel, is frequently amplified in B-cell lymphoma and functions as a tumour-promoting transcription factor. Here we report the surprising result that c-rel–/– mice display significantly earlier lymphomagenesis in ...
Bacon, C.M.   +9 more
core   +1 more source

Home - About - Disclaimer - Privacy